Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

8.97
+0.32003.70%
Volume:157.62K
Turnover:1.40M
Market Cap:296.74M
PE:-10.69
High:8.99
Open:8.65
Low:8.61
Close:8.65
52wk High:18.98
52wk Low:5.45
Shares:33.08M
Float Shares:22.52M
Volume Ratio:0.65
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8387
EPS(LYR):-0.9318
ROE:-176.94%
ROA:-12.39%
PB:15.27
PE(LYR):-9.63

Loading ...

NeuroPace Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 15

NeuroPace Price Target Maintained With a $17.00/Share by Cantor Fitzgerald

Dow Jones
·
May 14

NeuroPace price target raised to $16 from $14 at JPMorgan

TIPRANKS
·
May 14

Neuropace Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

BRIEF-Neuropace, Inc. Q1 Revenue USD 22.524 Million Versus. IBES Estimate USD 21.8 Million

Reuters
·
May 14

NeuroPace Inc. Reports 24% Increase in Q1 2025 Revenue to $22.5M, Raises Full-Year Revenue Guidance to $93-$97M

Reuters
·
May 14

NeuroPace Q1 EPS $(0.21) Beats $(0.24) Estimate, Sales $22.52M Beat $21.85M Estimate

Benzinga
·
May 14

NeuroPace (NPCE) Gets a Buy from Lake Street

TIPRANKS
·
May 12

Neuropace Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
May 10

NeuroPace’s Strong Market Position and Growth Potential Justify Buy Rating Amid Tariff Stability

TIPRANKS
·
Apr 16

BRIEF-Neuropace Provides Update On Tariff Status

Reuters
·
Apr 15

NeuroPace Reports 'Minimal impact' From Trump Tariffs

MT Newswires Live
·
Apr 15

NeuroPace Expects Minimal Impact from Trade Tariffs

TIPRANKS
·
Apr 15

NeuroPace expects minimal impact from tariffs

TIPRANKS
·
Apr 15

NeuroPace Provides Update on Tariff Status

GlobeNewswire
·
Apr 15

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

GlobeNewswire
·
Apr 08

NeuroPace (NPCE) Receives a Buy from Lake Street

TIPRANKS
·
Apr 03

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

GlobeNewswire
·
Apr 03

NeuroPace to End Stereo EEG Distribution Accord; 2025 Revenue Guidance Affirmed

MT Newswires Live
·
Apr 03

NeuroPace Shifts Focus to Core RNS System

TIPRANKS
·
Apr 03